Transferable resistance to cephalosporins, ureidopenicillins and trimethoprim. 1986

A Seckárová, and M Antal, and V Krcméry, and V Zikmundová, and V Lonská, and D Nanista, and V Kapániková, and J Sláma, and H Skacániová

Transferable resistance to classical Cephalosporins emerged three years ago among Enterobacteriaceae simultaneously in several hospitals and was associated with resistance to other betalactam drugs, i.e. with a transmissible TEM-like betalactamase. A systematic survey of incidence of R plasmids in Proteus sp. lead, in two district PHLs, to demonstration of transferable Azlocillin resistance. This resistance was most frequently associated with that for Carbenicillin, but also strains susceptible to CAR but resistant to AZL have been isolated. Trimethoprim resistance was in this country first described by Schŏn, but, since then, it is now frequently found transferable in polyresistant strains from hospitals, resistant also to betalactam antibiotics, Gentamicin and other drugs.

UI MeSH Term Description Entries
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D011815 R Factors A class of plasmids that transfer antibiotic resistance from one bacterium to another by conjugation. R Factor,R Plasmid,R Plasmids,Resistance Factor,Resistance Factors,Factor, R,Factor, Resistance,Factors, R,Factors, Resistance,Plasmid, R,Plasmids, R
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001390 Azlocillin A semisynthetic ampicillin-derived acylureido penicillin. Azlin,Azlocillin Sodium,Bay-e 6905,Securopen,Sodium Azlocillin,Azlocillin, Sodium,Bay e 6905,Baye 6905,Sodium, Azlocillin
D014295 Trimethoprim A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported. Proloprim,Trimpex

Related Publications

A Seckárová, and M Antal, and V Krcméry, and V Zikmundová, and V Lonská, and D Nanista, and V Kapániková, and J Sláma, and H Skacániová
June 1984, Casopis lekaru ceskych,
A Seckárová, and M Antal, and V Krcméry, and V Zikmundová, and V Lonská, and D Nanista, and V Kapániková, and J Sláma, and H Skacániová
May 1981, The Journal of infectious diseases,
A Seckárová, and M Antal, and V Krcméry, and V Zikmundová, and V Lonská, and D Nanista, and V Kapániková, and J Sláma, and H Skacániová
June 1998, Journal of chemotherapy (Florence, Italy),
A Seckárová, and M Antal, and V Krcméry, and V Zikmundová, and V Lonská, and D Nanista, and V Kapániková, and J Sláma, and H Skacániová
September 1983, The Journal of antimicrobial chemotherapy,
A Seckárová, and M Antal, and V Krcméry, and V Zikmundová, and V Lonská, and D Nanista, and V Kapániková, and J Sláma, and H Skacániová
March 1983, Health bulletin,
A Seckárová, and M Antal, and V Krcméry, and V Zikmundová, and V Lonská, and D Nanista, and V Kapániková, and J Sláma, and H Skacániová
October 1985, The Journal of hygiene,
A Seckárová, and M Antal, and V Krcméry, and V Zikmundová, and V Lonská, and D Nanista, and V Kapániková, and J Sláma, and H Skacániová
January 1981, Zeitschrift fur allgemeine Mikrobiologie,
A Seckárová, and M Antal, and V Krcméry, and V Zikmundová, and V Lonská, and D Nanista, and V Kapániková, and J Sláma, and H Skacániová
October 1985, The Journal of antimicrobial chemotherapy,
A Seckárová, and M Antal, and V Krcméry, and V Zikmundová, and V Lonská, and D Nanista, and V Kapániková, and J Sláma, and H Skacániová
September 1989, The Indian journal of medical research,
A Seckárová, and M Antal, and V Krcméry, and V Zikmundová, and V Lonská, and D Nanista, and V Kapániková, and J Sláma, and H Skacániová
August 1987, Lancet (London, England),
Copied contents to your clipboard!